Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
Plos One|March 6, 2015
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of survival and metastasis for recurrent hepatocellular carcinoma after transarterial chemoembolizationWenzhe Fan, Yingqiang Zhang, Yu Wang, et al.
American Journal of Cancer Research|January 12, 2022
Advanced hepatocellular carcinoma treated by transcatheter arterial chemoembolization with drug-eluting beads plus lenvatinib versus sorafenib, a propensity score matching retrospective studyMiao Xue, Yanqin Wu, Bowen Zhu, et al.
Journal of Translational Medicine|June 6, 2024
Elevated SLC1A5 associated with poor prognosis and therapeutic resistance to transarterial chemoembolization in hepatocellular carcinomaGuixiong Zhang, Yitai Xiao, Jizhou Tan, et al.
ACS Applied Materials & Interfaces|February 7, 2022
Doxorubicin-Loaded UiO-66/Bi<sub>2</sub>S<sub>3</sub> Nanocomposite-Enhanced Synergistic Transarterial Chemoembolization and Photothermal Therapy against Hepatocellular CarcinomaLingwei Liu, Jialang Zhuang, Jizhou Tan, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 12, 2018
Large hepatocellular carcinomas: treatment with transarterial chemoembolization alone or in combination with percutaneous cryoablationWei Cui, Wenzhe Fan, Kunbo Huang, et al.
The Oncologist|July 14, 2017
Feasibility and Efficacy of Microwave Ablation Combined with Iodine-125 Seed Implantation in Local Control of Recurrent Retroperitoneal Liposarcomas: Initial Clinical ExperienceMingjian Lu, Wang Yao, Tao Zhang, et al.
Cancer Communications (London, England)|May 17, 2018
Impact of type 2 diabetes mellitus on short-term and long-term outcomes of patients with esophageal squamous cell cancer undergoing resection: a propensity score analysisWang Yao, Yuqi Meng, Mingjian Lu, et al.
Cancer Management and Research|June 12, 2020
Dynamic Changes in the Neutrophil-to-Lymphocyte Ratio Predict the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationHongyu Wang, Chuyang Lin, Wenzhe Fan, et al.
Journal of Cancer Research and Therapeutics|June 1, 2020
Time to untreatable progression is an appropriate surrogate endpoint for overall survival in patients with hepatocellular carcinoma after transarterial chemoembolizationHongyu Wang, Bin Li, Yu Wang, et al.
World Journal of Urology|September 8, 2018
Efficacy of intra-arterial chemotherapy combined with intravesical chemotherapy in T1G3 bladder cancer when compared with intravesical chemotherapy alone after bladder-sparing surgery: a retrospective studyBin Huang, Jiabo Zheng, Zhijun Yao, et al.
Pageof 10